Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib-Reference-Cited by-同舟云学术

Association of albumin–bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib

Published:2021-04-11 Issue:7 Volume:26 Page:1257-1263
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Watanabe Daichi,Fujii Hironori,Yamada Yunami,Matsuhashi Nobuhisa,Makiyama Akitaka,Iihara Hirotoshi,Takahashi Takao,Kiyama Shigeru,Kobayashi Ryo,Yoshida Kazuhiro,Suzuki Akio

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-021-01910-2.pdf

Reference22 articles.

1. Grothey A, Van Cutsem E, Sobrero A et al (2013) Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381:303–312

2. Moriwaki T, Fukuoka S, Masuishi T et al (2020) Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study. Int J Clin Oncol 25:614–621

3. Aljubran A, Elshenawy MA, Kandil M et al (2019) Efficacy of regorafenib in metastatic colorectal cancer: a multi-institutional retrospective study. Clin Med Insights Oncol 13:1179554918825447

4. Del Prete M, Giampieri R, Loupakis F et al (2015) Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management. Oncotarget 6:33982–33992

5. Adenis A, de la Fouchardiere C, Paule B et al (2016) Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBACCA) nested within a compassionate use program. BMC Cancer 16:412

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative albumin-bilirubin score predicts short-term outcomes and long-term prognosis in colorectal cancer patients undergoing radical surgery;World Journal of Gastrointestinal Surgery;2024-07-27

2. Association between albumin–bilirubin grade and plasma trough concentrations of regorafenib and its metabolites M-2 and M-5 at steady-state in Japanese patients;Investigational New Drugs;2024-03-22

3. Clinical Significance of Albumin–Bilirubin Grade in Thoracic Esophageal Squamous Cell Carcinoma;Journal of Surgical Research;2024-03

4. Albumin-bilirubin score predicts trastuzumab resistance in HER2-positive breast cancer;Cancer Biomarkers;2023-12-15

5. Novel prognostic score based on the preoperative total bilirubin-albumin ratio and fibrinogen-albumin ratio in ampullary adenocarcinoma;World Journal of Gastrointestinal Surgery;2023-10-27